Enable JavaScript to visit this website.

Changing the future of breast cancer around the world begins with our commitment to:

  • Innovate

    through science and solutions that aim to improve patient outcomes

  • Educate

    to enhance knowledge of evolving patient needs

  • Activate

    the global community to develop resources that improve patient care

Activate

THE GLOBAL BREAST CANCER COMMUNITY

See the realities faced by patients with metastatic breast cancer (mBC) around the world and view some local initiatives to drive awareness and fight this disease.

United Kingdom

United Kingdom

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

BREAST CANCER NOW’S

CATALYST PROGRAMME

Pfizer has committed £10 million (USD $15M) over 3 years to fund research proposed by the Breast Cancer Now Catalyst Programme. The Programme allows the scientific community to propose research projects based on their insights into patient needs and understanding of cancer therapies, bringing together industry, researchers, and funders to advance the development of breast cancer treatments.

Find out about Breast Cancer Now’s Catalyst Programme

Learn More
Models used for illustrative purposes
Turkey

Turkey

Who We’re Fighting For:

YELIZ

Yeliz is a 40-year-old woman living with mBC in Istanbul, Turkey. Hear her talk about bringing awareness to the global mBC landscape from diagnosis to treatment for all those impacted.

Play
Yeliz’s Challenges
Play
Yeliz’s Diagnosis Story
Play
Yeliz’s Support System

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

Spain

Spain

Who We’re Fighting For:

Amelia

Meet Amelia, a 51-year-old woman with mBC living in Aragón, Spain. Hear her talk about her diagnosis and how her friends and family helped support her throughout the process.

Play
Amelia’s Challenges
Play
Amelia’s Support System
Play
Amelia’s Diagnosis Story

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

European Region

European Region

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

ME & METASTATIC BREAST CANCER

Some adults are fighting metastatic breast cancer (mBC). Others have loved ones with a new diagnosis. No matter their relationship with the disease, Me & mBC aims to help all those affected by offering solutions that are right for them. Our hope is that this site encourages all visitors to make the most of every day.

Find out more about Me & mBC

Learn More

BREAST CANCER MATTERS

Breast Cancer Matters brings together the voices and stories of those working every day to improve the lives of women living with breast cancer (BC) and metastatic breast cancer (mBC). Physicians, patients, advocates, researchers, organizations, institutions, and decision makers provide their personal perspectives on BC and mBC and where improvements are needed.

Find out more about Breast Cancer Matters

Learn More
United States

United States

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

A STORY HALF TOLD

A Story Half Told is an initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.

Find out about A Story Half Told

Learn More

ADVANCING SCIENCE THROUGH PFIZER-INVESTIGATOR RESEARCH EXCHANGE (ASPIRE)

The ASPIRE program underscores Pfizer’s commitment to supporting investigators in advancing their academic research in advanced breast cancer and other therapeutic areas.

Find out about the ASPIRE program

Learn More

AVON-PFIZER METASTATIC BREAST CANCER GRANTS PROGRAM

Since 2014, Pfizer and the Avon Breast Cancer Crusade have partnered to establish the Avon-Pfizer Metastatic Breast Cancer Grants Program to address the gaps in support available to women and men living with mBC.

Find out more about Avon-Pfizer Metastatic Breast Cancer Grants Program

Learn More

BREAST CANCER RESEARCH FOUNDATION’S (BCRF) DRUG RESEARCH COLLABORATIVE

BCRF has received a 3-year, $15 million grant from Pfizer, along with access to all of Pfizer’s marketed and pipeline assets, to support its Drug Research Collaborative. The collaborative offers a new model for bridging the gap between academic investigators and the industry partners who can provide access to developmental oncology drugs.

The program will initially support 6 laboratory studies and 3 clinical trials that will collectively benefit nearly 400 patients with metastatic disease. The clinical studies will be conducted and managed by the Translational Breast Cancer Research Consortium (TBCRC).

Find out about BCRF’s Drug
Research Collaborative

Learn More
Mexico

Mexico

Who We’re Fighting For:

Esther

Meet Esther, a 33-year-old woman with mBC living in Mexico City, Mexico. Hear her talk about her diagnosis and the strength she found in a support system.

Play
Esther’s Challenges
Play
Esther’s Support System
Play
Esther’s Diagnosis Story

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

Brazil

Brazil

Who We’re Fighting For:

Elfriede

Meet Elfriede, a 61-year-old woman from Saõ Paolo, Brazil. Hear her mBC story from diagnosis to treatment, and her support along the way.

Play
Elfriede’s Challenges & Triumphs
Play
Elfriede’s Support System
Play
Elfriede’s Treatment Journey

Programs Supporting
Innovation in Breast Cancer

Great progress comes through great collaboration. That’s why Pfizer awards grants, supports partnerships, and helps create resources around the globe to raise awareness and further extend the fight against breast cancer.

GLOBAL INITIATIVE

SPARC Mbc challenge

The Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC MBC Challenge) is an initiative of the Union for International Cancer Control (UICC) supported by Pfizer that aims to empower advocacy groups, hospital networks, support groups, and other organizations worldwide as they initiate projects to address the specific needs of women living with metastatic breast cancer.

Grants are awarded for projects focused on closing the gap in information, support, awareness, and policy between metastatic breast cancer and early breast cancer, as well as helping reduce the number of women first diagnosed at the metastatic stage of the disease.

Find out more about the SPARC MBC Challenge and the UICC

Learn More